Immune therapy engineered inside the body eases multiple sclerosis

TL;DR - A small clinical trial suggests that an engineered viral therapy can reprogram the immune system inside the body to eliminate cells implicated in multiple sclerosis. The early findings point to a potentially new way to treat the autoimmune disease, but the provided content does not report efficacy, safety, or durability data.

• The treatment uses a modified virus to deliver immune-engineering instructions in vivo.
• Its intended targets are disease-causing immune cells associated with multiple sclerosis.
• Evidence comes from a small trial, so the results are preliminary.
• The excerpt does not specify the viral vector, trial size, clinical outcomes, or adverse effects.